These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 16369966
21. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ. J Oral Maxillofac Surg; 2007 Jul; 65(7):1328-31. PubMed ID: 17577497 [Abstract] [Full Text] [Related]
22. Bisphosphonate-induced osteonecrosis of the jaw. Krueger CD, West PM, Sargent M, Lodolce AE, Pickard AS. Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010 [Abstract] [Full Text] [Related]
23. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. Grant BT, Amenedo C, Freeman K, Kraut RA. J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600 [Abstract] [Full Text] [Related]
24. Bisphosphonate-related osteonecrosis of the jaws (ONJ): a report of two cases. Pongchaiyakul C, Auraiwan K, Kotruchin P, Kularbkaew C. J Med Assoc Thai; 2007 Nov; 90(11):2494-8. PubMed ID: 18181340 [Abstract] [Full Text] [Related]
25. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients. Walter C, Al-Nawas B, du Bois A, Buch L, Harter P, Grötz KA. Cancer; 2009 Apr 15; 115(8):1631-7. PubMed ID: 19156913 [Abstract] [Full Text] [Related]
27. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. J Oral Maxillofac Surg; 2009 Apr 15; 67(4):850-5. PubMed ID: 19304045 [Abstract] [Full Text] [Related]
28. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children? Brown JJ, Ramalingam L, Zacharin MR. Clin Endocrinol (Oxf); 2008 Jun 15; 68(6):863-7. PubMed ID: 18221397 [Abstract] [Full Text] [Related]
29. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. Carlson ER, Basile JD. J Oral Maxillofac Surg; 2009 May 15; 67(5 Suppl):85-95. PubMed ID: 19371819 [Abstract] [Full Text] [Related]
30. Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis. Wilkinson GS, Kuo YF, Freeman JL, Goodwin JS. J Natl Cancer Inst; 2007 Jul 04; 99(13):1016-24. PubMed ID: 17596574 [Abstract] [Full Text] [Related]
31. Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases. Brooks JK, Gilson AJ, Sindler AJ, Ashman SG, Schwartz KG, Nikitakis NG. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jun 04; 103(6):780-6. PubMed ID: 17223592 [Abstract] [Full Text] [Related]
34. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases. Dimitrakopoulos I, Magopoulos C, Karakasis D. Int J Oral Maxillofac Surg; 2006 Jul 04; 35(7):588-93. PubMed ID: 16687238 [Abstract] [Full Text] [Related]
38. Bisphosphonates and osteonecrosis of the jaw. Sambrook P, Olver I, Goss A. Aust Fam Physician; 2006 Oct 04; 35(10):801-3. PubMed ID: 17019456 [Abstract] [Full Text] [Related]